HLB생명과학

067630KOSDAQ의료용품 및 기타 의약 관련제품 제조업

49.0 / 100

Reference Date: 2026-07-24

Financial Score13.5 / 40

News Sentiment18.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is undervalued vs. peers but the high debt ratio poses financial risk. Plunged 35.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

HLB Life Science operates four business divisions: Medicare, Biotech Development, Medical Device, and Energy, focusing on medical device manufacturing, pharmaceutical R&D, disposable syringe production, and solar EPC projects. Key clients include Abbott and Roche, and the company expanded its medical device market through the 2023 merger with Hwa Jin Medical and acquisition of Tinyco, which specializes in medical-grade nickel-titanium alloys.

Number of Employees

180people

Average Salary

48.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.184.0Point

PBR

0.84Industry Average 1.094.0Point

In line with industry avg

ROE

-28.70Industry Average -4.893.5Point

5.9x industry avg (excellent)

Debt Ratio

20.67Industry Average 6.860.0Point

3.0x industry avg (risky)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼25.5% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲5.0% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -9.8% (declining, 3yr)

Detailed News Sentiment

12 totalPositive 6Neutral 2Negative 4Average Sentiment Score 74.2

Positive
"FDA 지적 사항 해소"…HLB 그룹주 상한가
HLB생명과학의 FDA 승인 보류 조치가 자발적 개선 요구로 해결되어 주가가 상한가를 기록했다.
Negative
HLB, 리보세라닙 FDA 보완 요구에 ‘하한가’ 기록 [이런국장 저런...
HLB생명과학의 주가가 리보세라닙 FDA 허가 불발로 인해 2거래일 연속 급락했다.
Negative
HLB·펩트론 '동반 하한가'…하반기 K바이오 투자심리 흔드나
HLB생명과학과 펩트론의 동시 하한가는 하반기 바이오 투자에 부정적 영향을 미치고 있다.

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 2,045Won52-week high 5,15052-week low 1,640

1-month return0.0Point

1m -35.89% (strong drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-01
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-01
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-01
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-01
Neutral주식등의대량보유상황보고서(일반)2026-07-01